Pharmaceuticals

ACTEMRA (tocilizumab, known as RoACTEMRA within the EU) is the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody developed for the treatment of RA (rheumatoid arthritis) and is a novel approach to help tackle this debilitating disease. IL-6 has been identified as having a fundamental role in the inflammation process in RA.

For indication information see RoACTEMRA.

ACTEMRA is currently approved in Japan, the European Union (as RoACTEMRA), Switzerland, India, Moldova, Peru, Kuwait, Brazil and Liechtenstein and pending approvals in the US and other countries around the world.
more

Management of pain, fever and inflammation. more

Indicated in combination with chemotherapy for the treatment of advanced colorectal, breast, and lung cancer and in combination with interferon alfa for advanced renal cell cancer. more

Used in the treatment of infections. more

For the treatment of metastatic bone disease in patients with breast cancer. more

For the treatment of osteoporosis in postmenopausal women. more

Used in the prevention of organ rejection in patients receiving kidney, heart, or liver transplants. more

Beta-blocker for the treatment of hypertension and chronic heart failure (CHF). more

For sedation in the premedication in advance of diagnostic or operative interventions. more

Indicated in combination with other antiretroviral medicinal products for the treatment of HIVinfected patients who failed or could not tolerate previous treaments. more

Used in the treatment of HER2 positive breast cancer more

Invirase is indicated for the treatment of HIV infected adult patients, in combination with ritonavir and other antiretroviral medicinal products. more

Used in the prevention of nausea and vomiting associated with chemotherapy or radiation. more

Lucentis® (ranibizumab injection) is indicated for the treatment of neovascular (wet) age-related macular degeneration (AMD). more

Used to treat patients with the most common forms of cancer of the lymphatic system. more

Indicated for use in combination with methotrexate for reducing signs and symptoms in adult patients with moderately- to severely-active rheumatoid arthritis (RA). more

Used in the treatment of patients with Parkinson?s disease and restless leg syndrome (RLS). more

Used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD). more

Used to treat patients with symptomatic anaemia associated with chronic kidney disease (CKD) and to treat chemotherapy-related anaemia in cancer patients. more

Used for the prevention of neutropenia, i.e. infections following chemotherapy. more

Used in the treatment of patients with viral hepatitis. more

Used to treat patients with cystic fibrosis. more

Used to treat patients with severe forms of acne. more

RoACTEMRA (tocilizumab, known as ACTEMRA outside of the EU) is the first interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody developed for the treatment of RA (rheumatoid arthritis) and is a novel approach to help tackle this debilitating disease. IL-6 has been identified as having a fundamental role in the inflammation process in RA.

RoACTEMRA, in combination with methotrexate (MTX), is indicated for the treatment of adult patients with moderate to severe RA who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease modifying anti-rheumatic drugs (DMARDs) or tumour necrosis factor (TNF) antagonists. In these patients, RoACTEMRA can be given as monotherapy in cases of intolerance to methotrexate (MTX) or where continued treatment with MTX is inappropriate.
more

Used in the treatment of patients with osteoporosis and renal osteodystrophy. more

Used in the treatment of infections. more

Used in the treatment of patients with chronic hepatitis C, hairy cell leukemia, and AIDS-related Kaposi's sarcoma. more

For the prevention and treatment of influenza. more

For short-term management of moderate to severe acute pain. more

Used for the prevention of cytomegalovirus (CMV) infections in kidney, heart, and pancreas transplant patients. Used in the treatment of CMV retinitis in patients with AIDS. more

Used in the treatment of anxiety disorders. more

Used in the treatment of acute promyelocytic leukemia. more

Used in combination of other drugs to treat patients with HIV infections. more

Used to treat patients with colorectal, breast, or colon cancer more

Used to help lose weight for obese and overweight patients. more

Prevention of acute rejection. more